Area of research
Neurology · Epidemiology
Research interest
Research interests include Traumatic Brain Injury and Neurovascular Disturbances, Traumatic Brain Injury Research, S100 Proteins and Annexins, and Neuroinflammation and Neurodegeneration Mechanisms.
Identification of Distinct Biological Groups of Patients With Cryptogenic NORSE via Inflammatory Profiling
Edaravone: Advances on cytoprotective effects, pharmacological properties, and mechanisms of action
The game changer: UCH-L1 and GFAP-based blood test as the first marketed in vitro diagnostic test for mild traumatic brain injury
Parsimonious immune-response endotypes and global outcome in patients with traumatic brain injury
Contemporary Update on Clinical and Experimental Prostate Cancer Biomarkers: A Multi-Omics-Focused Approach to Detection and Risk Stratification
Inflammasome links traumatic brain injury, chronic traumatic encephalopathy, and Alzheimer’s disease
Revisiting HER2 in Prostate Cancer from an Inclusive Perspective: From Biomarkers to Omics
The utility of biomarkers in traumatic brain injuries in children: opportunities and challenges
Neuroinflammatory Biomarkers for Traumatic Brain Injury Diagnosis and Prognosis: A TRACK-TBI Pilot Study
Prognostic and Diagnostic Utility of Serum Biomarkers in Pediatric Traumatic Brain Injury
LC-MS/MS-Based Proteomics Approach for the Identification of Candidate Serum Biomarkers in Patients with Narcolepsy Type 1
Carvacrol decreases blood–brain barrier permeability post-diffuse traumatic brain injury in rats
Satureja khuzistanica Jamzad essential oil and pure carvacrol attenuate TBI-induced inflammation and apoptosis via NF-κB and caspase-3 regulation in the male rat brain
Association between Cerebrospinal Fluid and Serum Biomarker Levels and Diagnosis, Injury Severity, and Short-Term Outcomes in Patients with Acute Traumatic Spinal Cord Injury
Inflammasomes as biomarkers and therapeutic targets in traumatic brain injury and related-neurodegenerative diseases: A comprehensive overview
Identification of clinically relevant biomarkers of epileptogenesis — a strategic roadmap
SARS-CoV-2 and Stroke Characteristics
Blood-based traumatic brain injury biomarkers – Clinical utilities and regulatory pathways in the United States, Europe and Canada
On-tissue spatially resolved glycoproteomics guided by N-glycan imaging reveal global dysregulation of canine glioma glycoproteomic landscape
Combination of drug and stem cells neurotherapy: Potential interventions in neurotrauma and traumatic brain injury
Hydrogels for Advanced Stem Cell Therapies: A Biomimetic Materials Approach for Enhancing Natural Tissue Function
Novel biomarker signatures for idiopathic REM sleep behavior disorder
Paclitaxel Treatment and Proprotein Convertase 1/3 (PC1/3) Knockdown in Macrophages is a Promising Antiglioma Strategy as Revealed by Proteomics and Cytotoxicity Studies
RhoA Inhibitor Treatment At Acute Phase of Spinal Cord Injury May Induce Neurite Outgrowth and Synaptogenesis
Biofluid Proteomics and Biomarkers in Traumatic Brain Injury
Proteomic Analysis of the Spatio-temporal Based Molecular Kinetics of Acute Spinal Cord Injury Identifies a Time- and Segment-specific Window for Effective Tissue Repair
Human Traumatic Brain Injury Induces Autoantibody Response against Glial Fibrillary Acidic Protein and Its Breakdown Products